JRP Bio
AboutPipelinesBusinessPressContact
KOEN
Workspace
JRP Bio

Where botanicals meet evidence

JRP Bio standardizes traditional Korean medicine formulas and natural products, builds the evidence behind them, and secures regulatory approval to turn them into products people actually use.

JRP Bio is the business brand of Jaein R&P Co., Ltd.
Room 304, Global Center, Seoul Bio Hub, 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea

KOEN

Sitemap

  • About
  • Pipelines
  • Business
  • Press
  • Contact

Contact

  • bs@jrpbio.com
  • +82-2-6925-5568
  • Employee workspace
© 2026 Jaein R&P Co., Ltd. · All rights reserved.
Ginseng and herbs beside a flask of extract on a stone counter

JRPJourney from Research to People

Botanical Evidence Company

Where botanicals meet evidence

We standardize Korean medicine formulas and natural products, build preclinical, clinical and real-world evidence, and secure approval as medicines and functional ingredients.

View pipelines→Partner with us
42

SCI(E) publications

19 in the last three years

14

Granted Korean patents

Also granted in the US and Japan

4

MFDS IND approvals

3 phase 1 completed · phase 2a approved

2.4B KRW

Funding raised

Pre-A

  • Certified venture company
  • Seoul Hongneung Innopolis resident
  • TIPS (2023)
  • Minister of SMEs and Startups Award (2023)

How we build products

Every project goes through the same three steps


Food, functional food and medicine are not separate business lines — they are different targets reached through the same three steps.

  1. 01

    Specification

    Reproducible quality

    We document raw material specs, manufacturing conditions, marker compounds and lot records so the same quality can be reproduced.

  2. 02

    Evidence

    Preclinical · clinical · RWD

    We generate preclinical, clinical and real-world data in the format each target's review requires.

  3. 03

    Approval

    Approval · recognition · registration

    We pass regulatory review to obtain approvals, recognitions and registrations, and bring products to market.

TargetsPrescription drug (Rx)OTC drugIndividually recognized functional ingredientOverseas registration (FDA NDI, etc.)Functional-claim or general food ingredient

Key items

Our key items


Our flagship businesses — one going to market as a botanical drug, the other as a functional ingredient.

A gloved hand pipetting extract into test tubes
SH003Botanical drug

Selective against cancer cells, activating for immunity

An oral botanical drug candidate that standardizes a new combination of herbs based on a Korean medicine formula. It induces selective cancer cell death without toxicity to normal cells while activating the immune system.

  • Korea's first oral botanical anticancer IND
  • 3 phase 1 trials completed
  • Phase 2a approved in NSCLC
  • Immune function human study completed
Gastrodia tubers and slices beside an extraction vessel
HO601Sleep functional ingredient · LactoElata

Gastrodia fermented with our own lactic acid bacteria

Gastrodia elata fermented with JRP Bio's proprietary strain to increase its active constituents. We supply it first as a food ingredient and aim for recognition as an individually recognized functional ingredient after a human study.

  • Proprietary fermentation strain
  • Scale-up process secured
  • Building sleep evidence
  • LactoElata trademark in preparation

Pipelines

7 pipelines, 11 targets


Each asset gets a regulatory path designed for its purpose, and we publish progress at every step.

Full pipeline→
  • Complete
  • In progress
  • Planned
  • Not applicable
AssetTargetSpecEvidenceApproval
SH003
Rx (oncology combination)
OTC (fatigue · weakness)
Functional ingredient (immunity)
Overseas (FDA NDI)
HO601LactoElata
Functional ingredient (sleep)
Food ingredient
HO602
Functional ingredient
JI-HK601
Functional ingredient (immunity)
LA16001
Food ingredient
JI017
Rx
Sd-021
Rx
  • SH003
    • Rx (oncology combination)

      Spec
      Evidence
      Approval
    • OTC (fatigue · weakness)

      Spec
      Evidence
      Approval
    • Functional ingredient (immunity)

      Spec
      Evidence
      Approval
    • Overseas (FDA NDI)

      Spec
      Evidence
      Approval
  • HO601LactoElata
    • Functional ingredient (sleep)

      Spec
      Evidence
      Approval
    • Food ingredient

      Spec
      Evidence
      Approval
  • HO602
    • Functional ingredient

      Spec
      Evidence
      Approval
  • JI-HK601
    • Functional ingredient (immunity)

      Spec
      Evidence
      Approval
  • LA16001
    • Food ingredient

      Spec
      Evidence
      Approval
  • JI017
    • Rx

      Spec
      Evidence
      Approval
  • Sd-021
    • Rx

      Spec
      Evidence
      Approval

* Clinical, patent and research information is as of September 2026. Please confirm regulatory and patent status with the official records of the relevant authorities.

Evidence

We publish our evidence as a list


Every granted patent and SCI(E) paper is listed with KIPRIS and PubMed links. The lists are synced with the track record managed in our internal workspace.

Patents · publications→
14

Granted Korean patents

US 10,568,922 B2 · JP 6113356 B2

→
42

SCI(E) publications

PubMed · DOI

→
Gastrodia tubers and slices beside an extraction vessel

Natural Products Foundry

One formula in — a specified, evidenced, approved product out

Just as a type foundry turned manuscripts into standardized type, JRP Bio is building the Natural Products Foundry — development infrastructure that turns formulas into standardized product assets.

Explore the Foundry→
  1. 01

    Formulation

    Optimal combinations of core herbs from Korean medicine formulas

  2. 02

    Processing

    Fermentation and other pre-treatments to raise actives

  3. 03

    Extraction

    Extraction, concentration and drying to marker specs

Press

Latest news


All press releases→
  • 2026.09Company

    JRP Bio to open Jecheon Production Center in October

    A base for producing its standardized botanical ingredients — the first production infrastructure for the Natural Products Foundry

    Read release
  • 2026.03Intellectual property

    JRP Bio granted Korean patent for immune-enhancing use of SH003

    “Composition for enhancing immunity comprising a mixed herbal extract,” Korean Patent No. 10-2940993

    Read release
  • 2025.08Clinical · regulatory

    JRP Bio receives phase 2a IND approval for SH003 with docetaxel in NSCLC

    Moving to efficacy after three monotherapy and combination phase 1 trials

    Read release

Partners

Built together with


  • Hanpoong Pharm
  • Huontech
  • Kwangdong Pharmaceutical
  • Kyung Hee University Industry-Academic Cooperation Foundation
  • Kyung Hee University MRC
  • Sun Ten Pharmaceutical (Taiwan)
  • Seoul Bio Hub
  • Hanpoong Pharm
  • Huontech
  • Kwangdong Pharmaceutical
  • Kyung Hee University Industry-Academic Cooperation Foundation
  • Kyung Hee University MRC
  • Sun Ten Pharmaceutical (Taiwan)
  • Seoul Bio Hub

Looking for partners to build evidence-backed botanical products

We welcome inquiries about licensing and co-development, B2B ingredient supply and investment.

Get in touch→